Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura De Angelis

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Nature Communications|May 12, 2021
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survivalStefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2019
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cellsIsabella Orienti, Valentina Salvati, Giovanni Sette, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2020
A pre-existing population of ZEB2<sup>+</sup> quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancerFederica Francescangeli, Paola Contavalli, Maria Laura De Angelis, et al.
Frontiers in Immunology|April 24, 2023
Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profilesMartina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, et al.
Cell Death & Disease|March 1, 2019
Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseasesLudovica Grassi, Romina Alfonsi, Federica Francescangeli, et al.
Cell Death & Disease|July 24, 2019
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumorsIsabella Orienti, Federica Francescangeli, Maria Laura De Angelis, et al.
Gut|April 9, 2017
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cellsGwenola Manic, Michele Signore, Antonella Sistigu, et al.
Frontiers in Immunology|November 12, 2021
Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High PotencySabrina Mariotti, Antonio Capocefalo, Maria Vincenza Chiantore, et al.
Vaccine|December 18, 2013
Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine eraGianvincenzo Zuccotti, Chiara Mameli, Laura Daprai, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Nature Communications|May 12, 2021
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survivalStefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2019
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cellsIsabella Orienti, Valentina Salvati, Giovanni Sette, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2020
A pre-existing population of ZEB2<sup>+</sup> quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancerFederica Francescangeli, Paola Contavalli, Maria Laura De Angelis, et al.
Frontiers in Immunology|April 24, 2023
Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profilesMartina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, et al.
Cell Death & Disease|March 1, 2019
Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseasesLudovica Grassi, Romina Alfonsi, Federica Francescangeli, et al.
Cell Death & Disease|July 24, 2019
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumorsIsabella Orienti, Federica Francescangeli, Maria Laura De Angelis, et al.
Gut|April 9, 2017
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cellsGwenola Manic, Michele Signore, Antonella Sistigu, et al.
Frontiers in Immunology|November 12, 2021
Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High PotencySabrina Mariotti, Antonio Capocefalo, Maria Vincenza Chiantore, et al.
Vaccine|December 18, 2013
Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine eraGianvincenzo Zuccotti, Chiara Mameli, Laura Daprai, et al.
Pageof 5